PRECISION BIOSCIENCES INC Operating Cash Flow
PRECISION BIOSCIENCES INC (DTIL) reported Operating Cash Flow of -$25.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$13.44M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$11.94M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$11.25M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$15.27M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for fiscal 2025 was -$65.84M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for fiscal 2024 was -$58.45M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for fiscal 2023 was -$84.11M.
- PRECISION BIOSCIENCES INC net cash provided by (used in) operating activities for fiscal 2022 was -$45.75M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$25.38M 10-Q · filed 2026-08-06 | -$36.63M derived: sum of 3 quarters · filed 2026-08-06 | -$51.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$11.94M 10-Q · filed 2026-05-05 | -$23.19M derived: sum of 2 quarters · filed 2026-05-05 | -$38.46M derived: sum of 3 quarters · filed 2026-05-05 | -$58.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$11.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$26.52M derived: sum of 2 quarters · filed 2026-03-12 | -$46.79M derived: sum of 3 quarters · filed 2026-08-06 | -$65.84M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$15.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$35.54M derived: sum of 2 quarters · filed 2026-08-06 | -$54.59M 10-Q · filed 2025-11-03 | -$73.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$20.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$39.32M 10-Q · filed 2026-08-06 | -$58.01M derived: sum of 3 quarters · filed 2026-08-06 | -$63.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$19.05M 10-Q · filed 2026-05-05 | -$37.73M derived: sum of 2 quarters · filed 2026-05-05 | -$43.65M derived: sum of 3 quarters · filed 2026-05-05 | -$58.52M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$18.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$24.59M derived: sum of 2 quarters · filed 2026-03-12 | -$39.46M derived: sum of 3 quarters · filed 2026-03-12 | -$58.45M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$5.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$20.78M derived: sum of 2 quarters · filed 2025-11-03 | -$39.76M 10-Q · filed 2025-11-03 | -$48.19M derived: sum of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | -$14.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$33.85M 10-Q · filed 2025-08-07 | -$42.27M derived: sum of 3 quarters · filed 2025-08-07 | -$65.37M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$18.98M 10-Q · filed 2025-05-15 | -$27.40M derived: sum of 2 quarters · filed 2025-05-15 | -$50.50M derived: sum of 3 quarters · filed 2025-05-15 | -$71.63M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$8.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$31.52M derived: sum of 2 quarters · filed 2025-03-26 | -$52.65M derived: sum of 3 quarters · filed 2025-03-26 | -$84.11M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$23.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$44.23M derived: sum of 2 quarters · filed 2024-11-04 | -$75.69M 10-Q · filed 2024-11-04 | -$97.53M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$21.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$52.60M 10-Q · filed 2024-08-01 | -$74.44M derived: sum of 3 quarters · filed 2024-08-01 | -$45.26M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$31.46M 10-Q · filed 2024-05-13 | -$53.31M derived: sum of 2 quarters · filed 2024-05-13 | -$24.12M derived: sum of 3 quarters · filed 2024-05-13 | -$48.34M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$21.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $7.34M derived: sum of 2 quarters · filed 2024-03-27 | -$16.88M derived: sum of 3 quarters · filed 2024-03-27 | -$45.75M 10-K · filed 2024-03-27 |
| 2022-09-30 | $29.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.96M derived: sum of 2 quarters · filed 2023-11-07 | -$23.91M 10-Q · filed 2023-11-07 | -$47.59M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$24.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$53.10M 10-Q · filed 2023-08-04 | -$76.78M derived: sum of 3 quarters · filed 2023-08-04 | -$100.68M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$28.87M 10-Q · filed 2023-05-09 | -$52.55M derived: sum of 2 quarters · filed 2023-05-09 | -$76.46M derived: sum of 3 quarters · filed 2023-05-09 | -$107.80M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$23.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$47.59M derived: sum of 2 quarters · filed 2023-03-09 | -$78.92M derived: sum of 3 quarters · filed 2023-03-09 | -$10.85M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$23.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$55.24M derived: sum of 2 quarters · filed 2022-11-08 | $12.83M 10-Q · filed 2022-11-08 | -$624.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$31.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $36.73M 10-Q · filed 2022-08-08 | $23.28M derived: sum of 3 quarters · filed 2022-08-08 | $1.06M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $68.07M 10-Q · filed 2022-05-09 | $54.62M derived: sum of 2 quarters · filed 2022-05-09 | $32.40M derived: sum of 3 quarters · filed 2022-05-09 | $6.60M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$13.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$35.67M derived: sum of 2 quarters · filed 2022-03-15 | -$61.48M derived: sum of 3 quarters · filed 2022-03-15 | -$87.39M 10-K · filed 2022-03-15 |
| 2020-09-30 | -$22.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$48.02M derived: sum of 2 quarters · filed 2021-11-10 | -$73.93M 10-Q · filed 2021-11-10 | -$94.49M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$25.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$51.71M 10-Q · filed 2021-08-12 | -$72.27M derived: sum of 3 quarters · filed 2021-08-12 | -$86.24M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$25.91M 10-Q · filed 2021-05-13 | -$46.47M derived: sum of 2 quarters · filed 2021-05-13 | -$60.44M derived: sum of 3 quarters · filed 2021-05-13 | -$77.02M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$20.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$34.53M derived: sum of 2 quarters · filed 2021-03-18 | -$51.11M derived: sum of 3 quarters · filed 2021-03-18 | -$71.02M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$13.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$30.55M derived: sum of 2 quarters · filed 2020-11-10 | -$50.46M 10-Q · filed 2020-11-10 | -$63.37M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$16.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$36.48M 10-Q · filed 2020-08-13 | -$49.39M derived: sum of 3 quarters · filed 2020-08-13 | -$64.44M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$19.91M 10-Q · filed 2020-05-15 | -$32.82M derived: sum of 2 quarters · filed 2020-05-15 | -$47.87M derived: sum of 3 quarters · filed 2020-05-15 | -$57.18M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$12.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$27.96M derived: sum of 2 quarters · filed 2020-03-10 | -$37.27M derived: sum of 3 quarters · filed 2020-03-10 | -$51.72M 10-K · filed 2020-03-10 |
| 2018-09-30 | -$15.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$24.36M derived: sum of 2 quarters · filed 2019-11-12 | -$38.81M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$9.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$23.76M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$14.45M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |